ClinicalTrials.govpublic full text
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
crohn's disease, medi2070, inflammatory bowel disease, moderate to severe crohn's disease, il-23, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830348
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.